Cargando…
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
It is expected that the coronavirus disease 2019 (COVID-19) pandemic will leave large deficits in the budgets of many jurisdictions. Funding for other treatments, in particular new treatments, may become more constrained than previously expected. Therefore, a robust health technology assessment (HTA...
Autores principales: | Leahy, Joy, Hickey, Conor, McConnell, David, Cassidy, Owen, Trela-Larsen, Lea, Barry, Michael, Tilson, Lesley, McCullagh, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534734/ https://www.ncbi.nlm.nih.gov/pubmed/33127011 http://dx.doi.org/10.1016/j.jval.2020.09.003 |
Ejemplares similares
-
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
por: Lamrock, Felicity, et al.
Publicado: (2020) -
A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues
por: Podolsky, Meghan I., et al.
Publicado: (2022) -
Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom
por: Zala, Darshan, et al.
Publicado: (2020) -
Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
por: Caro, J. Jaime, et al.
Publicado: (2021) -
The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)
por: Mullins, C. Daniel, et al.
Publicado: (2020)